Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
12/29/2010 | EP2267023A2 KDR peptides and vaccines comprising the same |
12/29/2010 | EP2267022A2 KDR peptides and vaccines comprising the same |
12/29/2010 | EP2267021A2 KDR peptides and vaccines comprising the same |
12/29/2010 | EP2267020A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
12/29/2010 | EP2267019A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
12/29/2010 | EP2267018A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
12/29/2010 | EP2267017A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
12/29/2010 | EP2267016A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
12/29/2010 | EP2267015A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
12/29/2010 | EP2267004A2 Peptide derived from hepatitis C virus |
12/29/2010 | EP2267003A1 Biologically produced cyclic affinity tags |
12/29/2010 | EP2267002A2 Antimicrobial polypeptides |
12/29/2010 | EP2267001A2 Antimicrobial polypeptides |
12/29/2010 | EP2267000A2 Antimicrobial polypeptides |
12/29/2010 | EP2266986A1 Cytotoxins, Prodrugs, Linkers and Stabilizers useful therefor |
12/29/2010 | EP2265642A1 Biomarkers |
12/29/2010 | EP2265641A1 Biomarkers |
12/29/2010 | EP2265631A2 Novel antimicrobial peptides and their application |
12/29/2010 | EP2265630A2 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma |
12/29/2010 | EP1560558B1 Use of 3-position cyclosporin derivatives for hair growth |
12/29/2010 | CN1863558B Polyarginine-modified liposome capable of transferring into nucleus |
12/29/2010 | CN1856504B Anti-infarction molecules |
12/29/2010 | CN101932592A Antitumoral compounds |
12/29/2010 | CN101928458A Preparation method of multifunctional nanometer composite particle constructed by modified polymine |
12/29/2010 | CN101928334A Preparation method of mouse Ehf polypeptide and antibody thereof |
12/29/2010 | CN101928333A Human EIF4H polypeptide and preparation method of antibody thereof |
12/29/2010 | CN101928332A Preparation method of Human HNRPA0 polypeptide and antibody thereof |
12/29/2010 | CN101928331A New compound and application thereof |
12/29/2010 | CN101928330A New compound and application thereof |
12/29/2010 | CN101311188B Small molecule peptides inhibitor of human heparinase |
12/29/2010 | CA2766272A1 Soricidin derived peptides and methods for the detection of trpv-6 cancers and drug delivery |
12/29/2010 | CA2766040A1 Process for production of peptide thioester |
12/29/2010 | CA2761471A1 Biologically produced cyclic affinity tags |
12/28/2010 | US7858743 The peptides stimulate the activity and proliferation of CD4+ T lymphocytes; encoded by the SSX-4 tumor associated gene; human leukocye antigen (HLA) |
12/28/2010 | US7858738 Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
12/28/2010 | US7858737 Heterogeneous foldamers containing α, β, and/or γ-amino acids |
12/28/2010 | US7858679 Polymeric compositions and related methods of use |
12/28/2010 | US7858588 Oligodeoxynucleic acid modified with (thio)phosphate |
12/28/2010 | US7858585 A polypeptide hydrogel containing VKVKVKVKVDPPTKVEVKVKV amino acid sequence, that may be formed by the self-assembly of peptides in solution and brought about by a change of the hydrogel e.g. pH, ionic strength, temperature, concentration of specific ions; drug delivery; wound healing; tissue engineering |
12/28/2010 | US7858337 Process for the manufacture of a composite material |
12/28/2010 | US7858322 Method of determining inhibition of binding to TRPM7 protein |
12/28/2010 | US7858081 Peptide which is part of epitope in human IL-15 responsible for high-affinity binding of IL-15 to IL-15Ralpha chain, characterized in that it has sequence of region of human mature wild-type IL-15 from L44 to L52, or sequence of region of human mature wild-type IL-15 from E64 to I68 or from E64 to L69 |
12/23/2010 | WO2010147158A1 Gel enclosing a compound by means of low-molecular weight gelling agent |
12/23/2010 | WO2010146584A1 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer |
12/23/2010 | WO2010144968A1 Casein derived protease inhibitory peptides |
12/23/2010 | US20100324264 Synthesis of a peg-6 moiety from commercial low-cost chemicals |
12/23/2010 | US20100323973 Conjugates containing hydrophilic spacer linkers |
12/23/2010 | US20100323972 Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy |
12/23/2010 | US20100323969 Compounds Binding to P-Selectin |
12/23/2010 | US20100323966 FVIII Peptides and Their Use in Tolerising Haemophiliacs |
12/23/2010 | US20100323963 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
12/23/2010 | US20100323951 Antibacterial peptides active in systemic infections |
12/23/2010 | US20100323949 erythropoietin mimetic peptide derivative and its pharmaceutical salts, the preparation and uses thereof |
12/23/2010 | US20100323420 Regulated apoptosis |
12/23/2010 | US20100323377 Biochemical markers for cvd risk assessment |
12/23/2010 | US20100323021 Antitumoral treatments |
12/23/2010 | US20100322948 Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same |
12/23/2010 | US20100322857 Radiolabelled peptide based compounds and uses thereof |
12/23/2010 | US20100322856 Compositions and Methods for Inducing Angiogenesis |
12/23/2010 | DE102009025119A1 Herstellung und Verwendung antitumoraler, antibiotischer und insektizider Cyclodepsipeptide Production and use of antitumor, antimicrobial and insecticidal cyclodepsipeptides |
12/23/2010 | CA2776883A1 Antimicrobial and antibiofilm activity of cathelicidins |
12/23/2010 | CA2765423A1 Casein derived protease inhibitory peptides |
12/23/2010 | CA2765188A1 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer |
12/22/2010 | EP2264049A2 1-Desamino-8-d-arginyl vasopressin analogs |
12/22/2010 | EP2264048A2 Peptide des-[asp1]-[ala1],angiotensin-(1-7) agonist and pharmaceutical compounds for the treatment of diseases |
12/22/2010 | EP2264047A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same |
12/22/2010 | EP2263686A1 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
12/22/2010 | EP2263086A2 Biomarkers |
12/22/2010 | EP1596879B1 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis |
12/22/2010 | CN1923849B Preparation method of synthesizing octriotide from solid phase polypeptide |
12/22/2010 | CN1481390B Immunomodulatory peptides derived from heat shock proteins and uses thereof |
12/22/2010 | CN101921319A Rubiaceae-type cyclopeptides, medicinal compositions using same as active ingredients, and preparation method and application thereof |
12/22/2010 | CN101921318A Method for preparing antifreeze polypeptide through enzymolysis of pigskin collagen protein by utilizing alkali protease |
12/22/2010 | CN101921317A Anti-freeze polypeptide prepared by utilizing papain to carry out enzymolysis to pigskin collagen |
12/22/2010 | CN101921316A Frost-resisting polypeptide prepared by using pigskin collagen |
12/22/2010 | CN101921315A Artificially synthesized signal peptide and application thereof |
12/22/2010 | CN101921314A Brain-targeting neurotrophic factor fusion polypeptide for preventing and treating Alzheimer's disease |
12/22/2010 | CN101921313A Polypeptide for curing or preventing cancer or derivative product and application thereof |
12/22/2010 | CN101921312A Human HNRPF polypeptide and preparation method of antibody thereof |
12/22/2010 | CN101921311A Anti-freeze polypeptide prepared by enzymolysis of cow leather collagen through papain |
12/22/2010 | CN101921310A Dengue virus (DENV) specific HLA-A2 (Human Leukocyte Antigen-A2) restrictive epitope peptide and application thereof |
12/21/2010 | US7855179 Template-fixed peptidomimetics with antimicrobial activity |
12/21/2010 | US7855175 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production; anemia; genetic discorder; blood disorders; erythropoietin receptor agonists |
12/21/2010 | US7854931 Immunizing compostion and method for inducing an immune response against the beta-secretase cleavage site of amyloid precursor protein |
12/21/2010 | US7854919 Multivalent constructs for therapeutic and diagnostic applications |
12/21/2010 | CA2451909C High throughput assays for the proteolytic activities of clostridial neurotoxins |
12/21/2010 | CA2223833C Compounds and peptides that bind to the erythropoietin receptor |
12/21/2010 | CA2220753C Novel peptides and compositions which modulate apoptosis |
12/16/2010 | WO2010144344A2 Melanocortin receptor-specific peptides |
12/16/2010 | WO2010144341A2 Lactam-bridged melanocortin receptor-specific peptides |
12/16/2010 | WO2010144231A2 Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles |
12/16/2010 | WO2010144038A1 Melanocortin receptor-specific peptides |
12/16/2010 | WO2010143983A1 Assays for serological detection of syphilis |
12/16/2010 | WO2010143010A1 Identification, optimization and use of shared hla-b*0702 epitopes for immunotherapy |
12/16/2010 | WO2010142293A1 Compounds acting as peptide gap junction modulators, and uses thereof |
12/16/2010 | WO2010142258A1 Production and use of antitumoral, antibiotic and insecticidal cyclodepsipeptides |
12/16/2010 | WO2010142060A1 Lhrh antagonist with long potency and low histamine releasing effect |
12/16/2010 | WO2010142041A1 Serine rich peptides having antioxidative stress properties |
12/16/2010 | US20100317830 Bace455, an alternative splice variant of the human beta-secretase |
12/16/2010 | US20100317829 Ifbm's to promote the specific attachment of target analytes to the surface of orthopedic implants |